Blog
RSS FeedPosted by Michael Wonder on 06 Aug 2016
More on the transparency of public assessment reports in Europe and Australia
6 August 2016 - The TGA and EMA have recently described their experiences in publishing public assessment reports, and reflect ...
Posted by Michael Wonder on 05 Aug 2016
TGA publishes paper on transparency in medicines regulation
5 August 2016 - Co-authoring with the EMA, the TGA has published a peer-reviewed, free-to-view paper on transparency in medicines regulation. ...
Posted by Michael Wonder on 05 Aug 2016
TGA publishes AusPAR for Xiaflex
5 August 2016 - The TGA has published an AusPAR for Actelion's Xiaflex (collagenase clostridium histolyticum). ...
Posted by Michael Wonder on 01 Aug 2016
Australia's most common and expensive drugs revealed by PBS data
1 August 2016 - They may be the most common drug in medicine cabinets across the country, but statins have been ...
Posted by Michael Wonder on 28 Jul 2016
EMA publishes EPAR for Zepatier (grazoprevir with elbasvir)
28 July 2016 - The EMA has published an EPAR for Merck's Zepatier. ...
Posted by Michael Wonder on 28 Jul 2016
EMA publishes EPAR for Epclusa (sofosbuvir with velpatasvir)
28 July 2016 - The EMA has published an EPAR for Gilead's Epclusa. ...
Posted by Michael Wonder on 27 Jul 2016
EMA publishes EPAR for Qtern (saxagliptin hydrochloride with dapagliflozin propanediol monohydrate)
27 July 2016 - The EMA has published an EPAR for AstraZeneca's Qtern. ...
Posted by Michael Wonder on 27 Jul 2016
Ensuring Australians get most from community pharmacy
27 July 2016 - The Australian Government is ensuring Australians get the best experience possible from community pharmacy and wants to ...
Posted by Michael Wonder on 27 Jul 2016
Review process is an opportunity for pharmacy
27 July 2016 - The release of the discussion paper of the Review of Pharmacy Remuneration and Regulation is an important ...
Posted by Michael Wonder on 26 Jul 2016
ICER release final reports on obeticholic acid for treatment of PBC and NASH
26 July 2016 - The ICER has released two final reports, the first titled Obeticholic Acid for the Treatment of Primary ...
Posted by Michael Wonder on 26 Jul 2016
ICER releases final report on diabetes prevention programs
25 July 2016 - The Institute for Clinical and Economic Review has released a final evidence report and meeting summary titled ...
Posted by Michael Wonder on 19 Jul 2016
EMA publishes EPAR for Zinbryta (daclizumab)
19 July 2016 - The EMA has published an EPAR for Biogen's Zinbryta. ...
Posted by Michael Wonder on 18 Jul 2016
Report on the collection of under co-payment data 2014-15
18 July 2016 - The report on the collection of under co-payment data 2014-15 is now available. ...
Posted by Michael Wonder on 15 Jul 2016
Public Summary Documents - March 2016 meeting
15 July 2016 - The Public Summary Documents (initial decisions not to recommend and deferrals) from the March 2016 PBAC meeting ...
Posted by Michael Wonder on 14 Jul 2016
EMA publishes EPA for ceftazidime with avibactam (Zavicefta)
13 July 2016 - The EMA has published an EPAR for AstraZeneca's new combination antibiotic Zavicefta. ...